[HTML][HTML] Claudin-1,-3 and-4 proteins and mRNA expression in benign and malignant breast lesions: a research study
AM Tőkés, J Kulka, S Paku, Á Szik, C Páska… - Breast Cancer …, 2005 - Springer
Introduction We compared levels of protein and mRNA expression of three members of the
claudin (CLDN) family in malignant breast tumours and benign lesions. Methods Altogether, …
claudin (CLDN) family in malignant breast tumours and benign lesions. Methods Altogether, …
[HTML][HTML] Phylogenetic analysis of metastatic progression in breast cancer using somatic mutations and copy number aberrations
Several studies using genome-wide molecular techniques have reported various degrees
of genetic heterogeneity between primary tumours and their distant metastases. However, it …
of genetic heterogeneity between primary tumours and their distant metastases. However, it …
[HTML][HTML] The prognostic significance of tumour–stroma ratio in oestrogen receptor-positive breast cancer
Background: A high percentage of stroma predicts poor survival in triple-negative breast
cancers but is diminished in studies of unselected cases. We determined the prognostic …
cancers but is diminished in studies of unselected cases. We determined the prognostic …
Breast carcinoma subtypes show different patterns of metastatic behavior
The aim of our retrospective study was to analyze patterns of subtype specific metastatic
spread and to identify the time course of distant metastases. A consecutive series of 490 …
spread and to identify the time course of distant metastases. A consecutive series of 490 …
[HTML][HTML] Ki-67 as a controversial predictive and prognostic marker in breast cancer patients treated with neoadjuvant chemotherapy
…, BÁ Molnár, IA Molnár, S Vári-Kakas, J Kulka… - Diagnostic …, 2017 - Springer
Background Studies have partly demonstrated the clinical validity of Ki-67 as a predictive
marker in the neoadjuvant setting, but the question of the best cut-off points as well as the …
marker in the neoadjuvant setting, but the question of the best cut-off points as well as the …
[HTML][HTML] Correlations of differentially expressed gap junction connexins Cx26, Cx30, Cx32, Cx43 and Cx46 with breast cancer progression and prognosis
Background and Aims Connexins and their cell membrane channels contribute to the control
of cell proliferation and compartmental functions in breast glands and their deregulation is …
of cell proliferation and compartmental functions in breast glands and their deregulation is …
[HTML][HTML] Papillary lesions of the breast
Papillary lesions of the breast represent a heterogeneous group of lesions including benign
papillomas, papillomas with focal epithelial atypia, fully fledged ductal carcinoma in situ (…
papillomas, papillomas with focal epithelial atypia, fully fledged ductal carcinoma in situ (…
Distribution pattern of the Ki67 labelling index in breast cancer and its implications for choosing cut-off values
…, Z Varga, P Figueiredo, T Decker, C Focke, J Kulka… - The Breast, 2014 - Elsevier
The Ki67 labelling index (LI – proportion of staining cells) is widely used to reflect proliferation
in breast carcinomas. Several cut-off values have been suggested to distinguish between …
in breast carcinomas. Several cut-off values have been suggested to distinguish between …
Expression of tight junction protein claudin-4 in basal-like breast carcinomas
Claudins (CLDN) are tight junction proteins which contribute to the paracellular transport
and ionic permeability of various epithelia. In recent years they came into focus for their …
and ionic permeability of various epithelia. In recent years they came into focus for their …
Clinicopathological features and prognosis of pregnancy associated breast cancer–a matched case control study
…, Z Baranyák, O Kiss, M Dank, J Kulka - Pathology & Oncology …, 2014 - Springer
Pregnancy Associated Breast Cancer (PABC) manifests during pregnancy or within a year
following delivery. We sought to investigate differences in management, outcome, clinical, …
following delivery. We sought to investigate differences in management, outcome, clinical, …